| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |